Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy

Burns

Volumn 43, Issue 3, 2017, Pages 471-485

  Prauchner, Carlos André ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antioxidants; Co therapy; Inflammation; Oxidative stress; Selenium; Sepsis

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BETA GLUCAN; CREATINE KINASE; CREATININE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MELATONIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDOREDUCTASE; PEPTIDOGLYCAN; PEROXYNITRITE; POLYPHENOL; PROSTAGLANDIN SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENIUM; SUPEROXIDE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; 10-(6'-UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; ADENOSINE TRIPHOSPHATE; ORGANOPHOSPHORUS COMPOUND; UBIDECARENONE; UBIQUINONE; VITAMIN;

CRITICALLY ILL PATIENT; ELECTRON TRANSPORT; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LENGTH OF STAY; MEAN ARTERIAL PRESSURE; MEMBRANE POTENTIAL; MINERAL METABOLISM; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL PERMEABILITY; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; ORGAN DYSFUNCTION SCORE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY CHAIN; REVIEW; SEPSIS; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; METABOLISM; MITOCHONDRION; MULTIPLE ORGAN FAILURE; NECROSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; HUMANS; MELATONIN; MITOCHONDRIA; MULTIPLE ORGAN FAILURE; NECROSIS; NF-KAPPA B; ORGANOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; SELENIUM; SEPSIS; UBIQUINONE; VITAMINS;

EID: 85009251306     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2016.09.023     Document Type: Review

References (146)

1. [1] Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992), 1644–1655.
2. [2] Martin, G.S., Mannino, D.M., Eaton, S., Moss, M., The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003), 1546–1554.
3. [3] Parrillo, J.E., Burch, C., Shelhamer, J.H., Parker, M.M., Natanson, C., Schuette, W., A circulating myocardial depressant substance in human with septic shock. J Clin Investig 76 (1985), 1539–1553.
4. [4] Kumar, A., Thota, V., Dee, L., Olson, J., Uretz, E., Parrillo, J.E., Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996), 949–958.
5. [5] Kumar, A., Brar, R., Wang, P., Dee, L., Skorupa, G., Khadour, F., et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 276 (1999), R265–R276.
6. 2+ in intact cardiac myocyte. Circ Res 74 (1994), 970–978.
7. [7] Abraham, E., Nuclear factor-κB and its role in sepsis-associated organ failure. J Infect Dis 187:Suppl. 2 (2003), S364–S369.
8. [8] MacDonald, J., Galley, H.F., Webster, N.R., Oxidative stress and gene expression in sepsis. Br J Anaesth 90:2 (2003), 221–232.
9. [9] Parratt, J.R., Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 41 (1998), 31–39.
10. [10] Annane, D., Sebille, V., Charpentier, C., Bollaert, P.E., François, B., Korach, J.M., et al. Effect of treatment with low dose of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002), 862–871.
11. [11] Sjakste, N., Baumane, L., Boucher, J.L., Dzintare, M., Meirena, D., Sjakste, J., et al. Effects of γ-butyrobetaine and mildronate on nitric oxide production in lipopolysaccharide-treated rats. Basic Clin Pharmacol Toxicol 94 (2004), 46–50.
12. [12] Parihar, A., Parihar, M.S., Milner, S., Bhat, S., Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34 (2008), 6–17.
13. [13] Rudyk, O., Phinikaridou, A., Prysyazhna, O., Burgoyne, J.R., Botnar, R.M., Eaton, P., Protein kinase G oxidation is a major cause of injury during sepsis. Proc Natl Acad Sci U S A 110 (2013), 9909–9913.
14. [14] Morgan, M.J., Liu, Z.-G., Crosstalk of reactive oxygen and NF-κB signaling. Cell Res 21 (2011), 103–115.
15. [15] Yadav, U.C.S., Ramana, K.V., Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid Med Cell Longev, 2013 Article ID 690545, 11 pp.
16. [16] Takeda, K., Shimada, Y., Amano, M., Sakai, T., Okada, T., Yoshiya, I., Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 12 (1984), 957–959.
17. [17] Ogilvie, A.G., Groeneveld, A.B., Straub, J.P., Thijs, L.G., Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 17 (1991), 40–44.
18. [18] Goode, H.F., Cowley, H.C., Walker, B.E., Howdle, P.D., Webster, N.R., Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23 (1995), 645–646.
19. [19] Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P., Chappuis, P., Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med 26 (1998), 1536–1544.
20. [20] Mishra, V., Baines, M., Perry, S.E., McLaughlin, P.J., Carson, J., Wenstone, R., et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 26 (2007), 41–50.
21. [21] Sakr, Y., Reinhart, K., Bloos, F., Marx, G., Russwurm, S., Bauer, M., et al. Time course and relationship between selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anesth 98 (2007), 775–784.
22. [22] Borrelli, E., Roux-Lombard, P., Grau, G.E., Girardin, E., Ricou, B., Dayer, J., et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multi organ failure in patients at risk. Crit Care Med 24 (1996), 392–397.
23. [23] Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002), 219–223.
24. [24] Brealey, D., Karyampudi, S., Jacques, T.S., Novelli, M., Stidwill, R., Taylor, V., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286 (2004), R491–R497.
25. [25] Andrades, M., Ritter, C., Moreira, J.C.F., Dal-Pizzol, F., Oxidative parameters differences during non-lethal and lethal sepsis development. J Surg Res 125 (2005), 68–72.
26. [26] Sener, G., Toklu, H., Ercan, F., Erkanli, G., Protective effect of β-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol 5 (2005), 1387–1396.
27. [27] Sener, G., Toklu, H., Kapucu, C., Ercan, F., Erkanli, G., Kaçmaz, A., et al. Melatonin protects against oxidative stress organ injury in a rat model of sepsis. Surg Today 35 (2005), 52–59.
28. [28] Prauchner, C.A., Prestes, A.S., Rocha, J.B.T., Effects of diphenyl diselenide on oxidative stress induced by sepsis in rats. Pathol Res Pract 207 (2011), 554–558.
29. [29] Chanock, S.J., Benna, E.L.J., Smith, R.M., Babior, B.M., The respiratory burst oxidase. J Biol Chem 269 (1994), 24519–24522.
30. [30] Robinson, J.M., Badwey, J.A., Production of active oxygen species by phagocytic leukocytes. Immunol Ser 60 (1994), 159–178.
31. [31] Carré, J.E., Orban, J.-C., Re, L., Felsmann, K., Iffert, W., Bauer, M., et al. Survival in critical illness is associated with early activation of mitochondria biogenesis. Am J Respir Crit Care Med 182 (2010), 745–751.
32. [32] Crouser, E.D., Julian, M.W., Blaho, D.V., Pfeiffer, D.R., Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 30:2 (2002), 276–284.
33. [33] Crouser, E.D., Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4 (2004), 729–741.
34. [34] Svistunenko, D.A., Davies, N., Brealey, D., Singer, M., Cooper, C.E., Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components. Biochim Biophys Acta 1757 (2006), 262–272.
35. [35] Galley, H.F., Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 20 (2011), 1–8.
36. [36] Lemaster, J.J., Nieminen, A.-L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., et al. The mitochondrial permeability transition cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366 (1998), 177–196.
37. [37] Kim, J.-S., He, L., Lemaster, J.J., Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304 (2003), 463–470.
38. [38] Hotchkiss, R.S., Karl, I.E., The pathophysiology and treatment of sepsis. N Engl J Med 348:2 (2003), 138–150.
39. [39] Camici, P.G., Prasad, S.K., Rimoldi, O.E., Stunning, hibernation, and assessment of myocardial viability. Circulation 117 (2008), 103–114.
40. [40] Levy, R.J., Piel, D.A., Acton, P.D., Zhou, R., Ferrari, V.A., Karp, J.S., et al. Evidence of myocardial hibernation in the septic heart. Crit Care Med 33 (2005), 2752–2759.
41. [41] Hsu, B.-G., Lee, R.-P., Yang, F.-L., Harn, H.-J., Chen, H.I., Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci 79 (2006), 2010–2016.
42. [42] Matsumoto, S., Koga, H., Kusaka, J., Hagiwara, S., Kai, S., Shingu, C., et al. Effects of the antioxidant-enriched concentrated liquid diet ANOM on oxidative stress and multiple organ injury in patients with septic shock: a pilot study. J Anesth Clin Res 2 (2011), 1–5.
43. [43] Huang, T.-S., Shyu, Y.-C., Chen, H.-Y., Lin, L.-M., Lo, C.-Y., Yuan, S.-S., et al. Effect of parenteral selenium supplementation in critically III patients: a systematic review and meta-analysis. PLoS ONE 8:1 (2013), 1–9.
44. [44] Jones, D.P., Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295 (2008), C849–C868.
45. [45] Chance, B., Sies, H., Boveris, A., Hydroperoxide metabolism in mammalian organs. Physiol Rev 59 (1979), 527–605.
46. [46] Flohé, L., Gunzler, W.A., Schock, H.H., Glutathione peroxidase: a selenium enzyme. FEBS Lett 32 (1973), 132–134.
47. [47] Tapiero, H., Townsend, D.M., Tew, K.D., The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 57 (2003), 134–144.
48. [48] Rederstorff, M., Krol, A., Lescure, A., Understanding the importance of selenium and selenoproteins in muscle function. Cell Mol Life Sci 63 (2006), 52–59.
49. [49] Fialkow, L., Wang, Y., Downey, G.P., Reactive oxygen and nitrogen species as signaling regulating neutrophil function. Free Radic Biol Med 42 (2007), 153–164.
50. [50] Boekstegers, P., Weidenhofer, S., Pilz, G., Werdan, K., Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 19 (1991), 317–323.
51. [51] Sair, M., Etherington, P.J., Peter, C.W., Evans, T.W., Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med 29 (2001), 1343–1349.
52. [52] Fink, M.P., Cytophatic hypoxia. Mitochondrial dysfunction as a mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17 (2001), 219–237.
53. [53] Kozlov, A.V., Bahrami, S., Calzia, E., Dungel, P., Gille, L., Kuznetsov, A.V., et al. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?. Ann Intensive Care, 1, 2011, 41.
54. [54] Yassen, K., Galley, H.F., Lee, A., Webster, N.R., Mitochondrial redox state in the critically ill. Br J Anaesth 83 (1999), 325–327.
55. [55] Vanhorebeek, I., de Vos, R., Mesotten, D., Wouters, P.J., de Wolf-Peeters, C., van den Berghe, G., Protection of hepatocyte mitochondrial ultra structure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005), 53–59.
56. [56] Singer, M., The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5:1 (2014), 66–72.
57. [57] Quoilin, C., Mouithys-Mickalad, A., Lécart, S., Fontaine-Aupart, M.-P., Hoebeke, M., Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury. Biochim Biophys Acta – Bioenerg 1837:10 (2014), 1790–1800.
58. [58] Trumbeckaite, S., Opalka, J.R., Neuhof, C., Zierz, S., Gellerich, F.N., Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur J Biochem 268 (2001), 1422–1429.
59. [59] Gellerich, F.N., Trumbeckaite, S., Opalka, J.R., Gellerich, J.F., Chen, Y., Neuhof, C., et al. Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci Rep 22 (2002), 99–113.
60. 2+ transfer in the control of apoptosis. Oncogene 27:50 (2008), 6407–6418.
61. [61] Loor, G., Kondapalli, J., Iwase, H., Chandel, N.S., Waypa, G.B., Guzy, R.D., et al. Mitochondrial oxidant stress triggers cell death in simulated ischemia–reperfusion. Biochim Biophys Acta 1813 (2011), 1382–1394.
62. [62] Orrenius, S., Gogvadze, A., Zhivotovsky, B., Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47 (2007), 143–183.
63. [63] Adrie, C., Bachelet, M., Vayssier-Taussat, M., Russo-Marie, F., Bouchaert, I., Adib-Conquy, M., et al. Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 164 (2001), 389–395.
64. [64] Garrabou, G., Morén, C., López, S., Tobías, E., Cardellach, F., Miró, O., et al. The effects of sepsis on mitochondria. J Infect Dis 205 (2012), 392–400.
65. [65] Watts, J.A., Kline, J.A., Thornton, L.R., Grattan, R.M., Brar, S.S., Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J Mol Cell Cardiol 36 (2004), 141–150.
66. [66] Sakaguchi, S., Abe, H., Sakaguchi, O., Calcium behavior in endotoxin-poisoned mice: especially calcium accumulation in mitochondrion. Microbiol Immunol 28 (1984), 517–527.
67. [67] Sakaguchi, S., Ibata, H., Yokota, K., Participation of calcium ion on depletion mechanism of liver glycogen by purified glucocorticoid antagonizing factor released in blood during endotoxemia. Microbiol Immunol 34 (1990), 985–994.
68. 2+ concentration of endotoxin-injected mice livers. Biol Pharm Bull 16 (1993), 808–810.
69. [69] Sakaguchi, S., Ibata, H., Yokota, Y., Effect of calcium ion on lipid peroxide formation in endotoxemic mice. Microbiol Immunol 33 (1989), 99–110.
70. [70] Deniaud, A., Dein, E.L.O.S., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27 (2008), 285–299.
71. 2+-ATPase (SERCA) in turtle muscle and liver during acute exposure to anoxia. J Exp Biol 213 (2010), 17–25.
72. 2+-ATPase (SERCA) by decreasing mitochondrial ATP production. J Biol Chem 286 (2011), 32533–32541.
73. [73] Huang, L.J., Hsu, C., Tsai, T.N., Wang, S.-J., Yang, R.-C., Suppression of mitochondrial ATPase inhibitor protein (IF1) in the liver of late septic rats. Biochim Biophys Acta 1767 (2007), 888–896.
74. [74] Marik, P.E., Bellomo, R., Lactate clearance as a target of therapy in sepsis: a flawed paradigm. OA Crit Care 1:1 (2013), 1–6.
75. [75] Bakker, J., Njisten, M.W.N., Jansen, T.C., Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care 3 (2013), 1–8.
76. [76] Fredriksson, K., Tjäder, I., Keller, P., Petrovic, N., Ahlman, B., Schéele, C., et al. Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS ONE, 3(11), 2008, e3686.
77. [77] Naik, E., Dixit, V.M., Mitochondrial reactive species drive proinflammatory cytokine production. J Exp Med 208:3 (2011), 417–420.
78. [78] Hughes, G., Murphy, M.P., Ledgerwood, E.C., Mitochondrial reactive species regulate the temporal activation of nuclear factor κB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-target antioxidant. Biochem J 389 (2005), 83–89.
79. [79] Marletta, M.A., Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 14 (1989), 488–492.
80. [80] Kone, B.C., Baylis, C., Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272 (1997), F561–F578.
81. [81] van Faassen, E.E., Bahrami, S., Feelisch, M., Hogg, N., Kelm, M., Kim-Shapiro, D.B., et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 29:5 (2009), 683–741.
82. [82] Billiar, T.R., Nitric oxide: novel biology with clinical relevance. Ann Surg 221 (1995), 339–349.
83. [83] Szabo, C., Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3 (1995), 2–32.
84. [84] Lowes, D.A., Thottakam, B.M., Webster, N.R., Murphy, M.P., Galley, H.F., The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 45 (2008), 1559–1565.
85. [85] Bultinck, J., Sips, P., Vakaet, L., Brouckaert, P., Cauwels, A., Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB 20 (2006), E1619–E1627.
86. [86] Boveris, A., Alvarez, S., Navarro, A., The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med 23:9 (2002), 1186–1193.
87. [87] Szabo, C., Salzman, A.L., Ischiropoulos, H., Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 363 (1995), 235–238.
88. [88] Minc-Colomb, D., Tsarfaty, I., Schwartz, J.P., Expression of inducible nitric oxide synthase by neurons following exposure to endotoxin and cytokine. Br J Pharmacol 112 (1994), 720–722.
89. [89] Landry, D.W., Oliver, J.A., The pathogenesis of vasodilatory shock. N Engl J Med 345 (2001), 588–595.
90. [90] Rudiger, A., Singer, M., Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35 (2007), 1599–1608.
91. [91] Boyle, W.A., Parvathaneni, L.S., Bourlier, V., Sauter, C., Laubach, V.E., Cobb, J.P., iNOS expression modulates microvascular responsiveness in endotoxin-challenged mice. Cir Res 87 (2000), e18–e24.
92. [92] Escames, G., López, L.C., Ortiz, F., López, A., Garcia, J.A., Ros, E., et al. Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS 274 (2007), 2135–2147.
93. [93] Ballard-Croft, C., Maass, D.L., Sikes, P.J., Horton, J.W., Sepsis and burn complicated by sepsis alter cardiac transporter expression. Burns 33 (2007), 72–80.
94. [94] Geisen, K., Vegh, A., Krause, E., Papp, J.G., Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res 28 (1996), 496–507.
95. [95] Gardiner, S.M., Kemp, P.A., March, J.E., Bennett, T., Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol 128 (1999), 1772–1778.
96. [96] Ali, E.M.M., Hamdy, S.M., Mohamed, T.M., Nitric oxide synthase and oxidative stress: regulation of nitric oxide synthase. Lushchak, V., (eds.) Oxidative stress – molecular mechanisms and biological effects, 2012, InTech 978-953-51-0554-1, 10.5772/32835 Available from: http://www.intechopen.com/books/oxidative-stress-molecular-mechanisms-and-biological-effects/nitric-oxide-synthase-as-oxidative-stress-regulation-of-nitric-oxide-synthase.
97. [97] Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnock, J.S., Tannenbaum, S.R., DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 89 (1992), 3030–3034.
98. [98] Radi, R., Nitric oxide, oxidants and protein tyrosine nitration. Proc Natl Acad Sci U S A 101 (2004), 4003–4008.
99. [99] Flesch, M., Kilter, H., Cremers, B., Laufs, U., Südkamp, M., Ortmann, M., et al. Effects of endotoxin on human myocardial contractility: involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 33 (1999), 1062–1070.
100. [100] Bronw, G.C., Borutaite, V., Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75 (2007), 283–290.
101. [101] McCall, T.B., Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J 261 (1989), 293–296.
102. [102] Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87 (1990), 1620–1624.
103. [103] Shiva, S., Sack, M., Greer, J., Duranski, M., Ringwood, L., Burwell, L., et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204 (2007), 2089–2102.
104. [104] López, A., Lorente, J.A., Steingrub, J., Bakker, J., McLuckie, A., Willatts, S., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32 (2004), 21–30.
105. [105] Vincent, J.L., Zhang, H., Szabo, C., Preiser, J.-C., Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161 (2000), 1781–1785.
106. [106] Kilbourn, R.G., Griffith, O.W., Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84 (1992), 82–877.
107. [107] Szabó, C., Thiemermann, C., Invited opinion: role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and thermal injury. Shock 2 (1994), 145–155.
108. [108] MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., et al. Altered responses to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthase. Cell 81 (1995), 641–650.
109. [109] Nathan, C., Xie, Q.-W., Regulation of biosynthesis of nitric oxide. J Biol Chem 269 (1994), 13725–13728.
110. [110] Griscavage, J.M., Wilk, S., Ignarro, L.J., Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc Natl Acad Sci U S A 93 (1996), 3308–3312.
111. [111] Ganster, R.W., Taylor, B.S., Shao, L., Geller, D.A., Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kB. Proc Natl Acad Sci U S A 98 (2001), 8638–8643.
112. [112] Blackwell, T.S., Yull, F.E., Chen, C.-L., Venkatakrishnan, A., Blackwell, T.R., Hicks, D.J., et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 162 (2000), 1095–1101.
113. [113] Xie, Q.-W., Whisnant, R., Nathan, C., Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994), 4705–4708.
114. [114] Zhong, H., May, M.J., Jimi, E., Ghosh, S., The phosphorylation status of nuclear NF-kB determines its association with CBP/p300 or HADAC-1. Mol Cell 9 (2002), 625–636.
115. [115] Pantano, C., Reynaert, N.L., van der Vliet, A., Janssen-Heininger, Y.W., Redox-sensitive kinases of the nuclear factor-κB signaling pathway. Antioxid Redox Sig 8:9 (2006), 1791–1806.
116. [116] Groen, A., Lemeer, S., van der Wijk, T., Overvoorde, J., Heck, A.J., Ostman, A., et al. Differential oxidation of protein-tyrosine phosphatases. J Biol Chem 280:11 (2005), 10298–10304.
117. [117] Whisler, R.L., Goyette, M.A., Grants, I.S., Newhouse, Y.G., Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch Biochem Biophys 319:1 (1995), 23–35.
118. [118] den Hertog, J., Groen, A., van der Wijk, T., Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434 (2005), 11–15.
119. [119] Murphy, M.P., Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777 (2008), 1028–1031.
120. [120] Lowes, D.A., Webster, N.R., Murphy, M.P., Galley, H.F., Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth 110:3 (2013), 472–480.
121. [121] Supinski, G.S., Murphy, M.P., Callahan, L.A., MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 297 (2009), R1095–R1102.
122. [122] Rodriguez-Cuenca, S., Cochemé, H.M., Logan, A., Abakumova, I., Prime, T.A., Rose, C., et al. Consequences of long-term oral administration of the mitochondria-target antioxidant MitoQ to wild-type mice. Free Radic Biol Med 48 (2010), 161–172.
123. [123] Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birks, A.V., Schiller, P.W., et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279:33 (2004), 34682–34690.
124. [124] Blackwell, T.S., Blackwell, T.R., Holden, E.P., Christman, B.W., Christman, J.W., In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157:4 (1996), 1630–1637.
125. [125] Kim, J.-Y., Lee, S.-M., Effect of ascorbic acid on hepatic vasoregulatory gene expression during polymicrobial sepsis. Life Sci 75 (2004), 2015–2026.
126. [126] Kim, J.-Y., Lee, S.-M., Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis. Eur J Pharmacol 534 (2006), 202–209.
127. [127] Prauchner, C.A., A importância do selênio para a agropecuária e saúde humana. 2014, Editora UFSM, Santa Maria (RS/Brasil).
128. [128] Sakaguchi, S., Iizuka, Y., Furusawa, S., Tanaka, Y., Takayanagi, M., Takayanagi, Y., Roles of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J774A.1 cells. Toxicol Lett 118 (2000), 69–77.
129. [129] Manzanares, W., Biestro, A., Galusso, F., Torre, M.H., Mañay, N., Pittini, G., et al. Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?. Intensive Care Med 35 (2009), 882–889.
130. [130] Angstwurm, M.W., Engelmann, L., Zimmermann, T., Lehmann, C., Spes, C.H., Abel, P., et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:1 (2007), 118–126.
131. [131] Manzanares, W., Dhaliwal, R., Jiang, X., Murch, L., Heyland, L.D.K., Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care, 16, 2012, R66.
132. [132] Hardy, G., Hardy, I., Manzanares, W., Selenium supplementation in the critically ill. Nutr Clin Pract 27 (2012), 21–33.
133. [133] Angstwurm, M.W., Schottdorf, J., Schopohl, J., Gaertner, R., Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27:9 (1999), 1807–1813.
134. [134] Straliotto, M.R., Hort, M.A., Fiuza, B., Rocha, J.B.T., Farina, M., Chiabrando, G., et al. Diphenyl diselenide modulates oxLDL-induced cytotoxicity in macrophages by improving the redox signaling. Biochimie 95:8 (2013), 1544–1551.
135. [135] Shimohashi, N., Nakamuta, M., Uchimura, K., Sugimoto, R., Iwamoto, H., Enjoji, M., et al. Oxide and tumor necrosis factor-α production by the modulation of Jun-N-terminal kinase and the NF-κB signaling pathway in rat Kupffer cells. J Cell Biochem 78 (2000), 595–606.
136. [136] Lowes, D.A., Galley, H.F., Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. Biochem J 436 (2011), 123–132.
137. [137] Kim, I.Y., Stadtman, T.C., Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 94 (1997), 12904–12907.
138. [138] Kretz-Remy, C., Arrigo, A.-P., Selenium: a key element that controls NF-κB activation and IκBα half-life. Biofactors 14 (2001), 117–125.
139. [139] Prabhu, K.S., Zamamiri-Davis, F., Stewart, J.B., Thompson, J.T., Sordillo, L.M., Reddy, C.C., Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-κB in up-regulation. Biochem J 366 (2002), 203–209.
140. [140] Matthews, J.R., Wakasugi, N., Virelizier, J.L., Yodoi, J., Hay, R.T., Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20 (1992), 3821–3830.
141. [141] Harper, R., Wu, K., Chang, M.M., Yoneda, K., Pan, R., Reddy, S.P., et al. Activation of nuclear factor-κB transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetylcysteine and glutathione. Am J Respir Cell Mol Biol 25 (2001), 178–185.
142. [142] Allingstrup, M., Afshari, A., Selenium supplementation for critically ill adults. Cochrane Database Syst Rev(7), 2015, 1–67 [Review].
143. [143] Andrade, A.A.A., Gayer, C.R.M., Nogueira, N.P.A., Paes, M.C., Bastos, V.L.F.C., Neto, J.C.B., et al. The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis. J Inflamm 11 (2014), 1–10.
144. [144] Costa, N.A., Gut, A.L., Dorna, M.S., Pimentel, J.A.C., Cozzolino, S.M.F., Azevedo, P.S., et al. Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock. J Crit Care 29 (2014), 249–252.
145. [145] Bakker, S.J.L., Leunissen, K.M.L., Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi. Med Hypotheses 45:3 (1995), 265–267.
146. [146] DiNicolantonio, J.J., Niazi, A.K., Lavie, C.J., O'Keefe, J.H., Ventura, H.O., Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest Heart Fail 19 (2013), 214–222.